Catalyst Pharmaceuticals Inc (CPRX)

Inventory turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cost of revenue (ttm) US$ in thousands 78,189 81,414 76,304 63,600 61,026 47,353 42,851 38,449 34,393 30,546 26,191 23,093 21,884 19,406 17,975 17,570 17,040 16,568 17,076 17,198
Inventory US$ in thousands 19,541 20,017 18,014 19,953 15,644 9,035 10,751 10,328 6,805 7,132 7,850 7,827 7,870 6,950 7,097 4,390 4,651 4,748 1,828 2,211
Inventory turnover 4.00 4.07 4.24 3.19 3.90 5.24 3.99 3.72 5.05 4.28 3.34 2.95 2.78 2.79 2.53 4.00 3.66 3.49 9.34 7.78

December 31, 2024 calculation

Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $78,189K ÷ $19,541K
= 4.00

The inventory turnover ratio measures how many times a company's inventory is sold and replaced over a specific period. A higher turnover ratio indicates efficient inventory management, as the company is selling its products quickly. In the case of Catalyst Pharmaceuticals Inc, the inventory turnover ratio fluctuated over the analyzed period, ranging from a high of 9.34 in June 2020 to a low of 2.53 in June 2021.

Overall, there seems to be some inconsistency in the management of inventory within Catalyst Pharmaceuticals Inc, as the ratio varied significantly throughout the reported periods. The company experienced a relative decrease in inventory turnover in the latter half of 2021 and 2022. However, it showed signs of improvement in the subsequent periods.

Further analysis and comparison with industry benchmarks could provide more insights into the effectiveness of Catalyst Pharmaceuticals Inc's inventory management strategies.